Oragenics
OGEN
16 hedge funds and large institutions have $8.63M invested in Oragenics in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
23% more funds holding
Funds holding: 13 → 16 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
18% less capital invested
Capital invested by funds: $10.5M → $8.63M (-$1.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$53.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$21.5K |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$21.5K |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$10.8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$10.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$9K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$3K |
OGEN Hedge Fund Activity: Q1 2017 in Review
16 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2017, worth a combined $8.63M — down 18% from $10.5M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new OGEN positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Wells Fargo, opening a new position worth an estimated $53.9K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $9K sold.
- 16 institutional investors held Oragenics (OGEN) as of Q1 2017, up from 13 in Q4 2016.
- Funds reported $8.63M of Oragenics stock for Q1 2017, down 18% quarter-over-quarter.
- 4 funds opened new Oragenics positions in Q1 2017 and 1 closed out, a net change of +3 holders.
- The largest Oragenics buyer in Q1 2017 was Wells Fargo, an estimated $53.9K added.
- The largest Oragenics seller in Q1 2017 was Susquehanna International Group, an estimated $9K sold.
Based on aggregated 13F filings for Q1 2017.